CLW

Clearwater Paper Corp. 2010 Form 10-K Summary

Business Context and Reporting Period

This Annual Report covers the fiscal year ended December 31, 2010. Clearwater Paper Corporation operates two primary segments: Consumer Products (private label tissue) and Pulp and Paperboard (bleached paperboard, pulp, and wood products). A defining event of the period was the acquisition of Cellu Tissue Holdings, Inc. on December 27, 2010, for $247.0 million in cash, significantly expanding the company's national footprint and tissue manufacturing capacity. The company is an accelerated filer incorporated in Delaware.

Key Financial Metrics

Note: 2010 results include four days of Cellu Tissue operations. 2009 results included a one-time $170.6 million Alternative Fuel Mixture Tax Credit (AFMTC) which significantly inflated earnings for that year.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 9.8% to $1.37 billion, driven by a 17.4% increase in Pulp and Paperboard sales (due to higher pulp and paperboard prices) and a 2.9% increase in Consumer Products sales (excluding Cellu Tissue).
• Profitability Decline: Net earnings decreased 59.5% to $73.8 million. This decline is primarily attributable to the absence of the $170.6 million AFMTC recorded in 2009, higher pulp costs (up 43% in the Consumer Products segment), and increased interest expense due to new debt issuance.
• Debt Expansion: Long-term debt increased by $390 million to $538.3 million. This was necessitated by the issuance of $375 million in 7.125% Senior Notes in October 2010 to finance the Cellu Tissue acquisition.
• Segment Performance:
  • Consumer Products: Operating income dropped from $122.1 million to $63.7 million, largely due to a $43.9 million increase in pulp costs.
  • Pulp and Paperboard: Operating income fell from $191.9 million to $81.9 million, reflecting the loss of the AFMTC benefit, though underlying operating income (excluding the credit) actually increased by $60.7 million due to higher sales volumes and prices.

Guidance, Outlook, and Risks

Outlook and Strategy: Management is focused on integrating Cellu Tissue and constructing a new Through-Air-Dried (TAD) tissue manufacturing facility in Shelby, North Carolina, with an estimated total cost of $260-$280 million. The company expects capital expenditures for 2011 to range between $175-$180 million. The effective tax rate for 2011 is estimated at approximately 34.0% (excluding discrete items).

Key Risks and Contingencies:

• Integration Risk: Challenges in integrating Cellu Tissue operations, systems, and personnel could delay anticipated synergies.
• Raw Material Volatility: The company is a net buyer of pulp; prices increased significantly in 2010 due to global shortages. Future earnings are sensitive to wood fiber and energy costs.
• Customer Concentration: Three customers (including Kroger) accounted for approximately 61% of Consumer Products segment sales (excluding Cellu Tissue) and 25% of total net sales in 2010.
• Debt Covenants: The company must maintain a minimum fixed charge coverage ratio of 1.0-to-1.0 under its credit facility if availability falls below $50 million. As of year-end, the ratio was 1.6-to-1.0.
• Tax Credit Uncertainty: While the company recognized a $27.1 million after-tax benefit from the Cellulosic Biofuel Producer Credit (CBPC) in Q4 2010, there is uncertainty regarding the retention of these credits and potential IRS audits.

Investor Verification Checklist

• Debt Service Capacity: Verify the company's ability to service the new $375 million note (7.125% interest) and existing $150 million note (10.625% interest) amidst rising operating costs.
• Cellu Tissue Integration: Monitor the realization of synergies and the successful integration of Cellu Tissue's IT and manufacturing systems.
• Pulp Pricing Trends: Track global pulp prices and the company's ability to pass cost increases to customers, given the 43% cost increase experienced in 2010.
• Shelby, NC Project: Review progress and cost overruns on the new TAD facility construction, which is a major capital commitment.
• Tax Credit Status: Confirm the final status of the CBPC and AFMTC credits with the IRS to ensure no future clawbacks or tax liabilities.